Literature DB >> 24819285

IgE-mediated sensitization to malassezia in atopic dermatitis: more common in male patients and in head and neck type.

Petra Brodská1, Petr Panzner, Karel Pizinger, Peter Schmid-Grendelmeier.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Malassezia, the predominant skin microbiota fungus, is considered to exacerbate AD, especially in a subset of patients with head and neck type AD (HNAD). In the present study, the relationship between AD and sensitization to Malassezia antigens was investigated.
METHODS: We assessed 173 patients with AD. The severity of eczema was determined with Eczema Area and Severity Index (EASI); the type of AD, namely, head and neck type, was reported as well. The total serum IgE and specific IgE to Malassezia were determined and correlated with clinical picture of AD, sex, age, and the EASI.
RESULTS: Total IgE was elevated in 77.7% of patients. Specific IgE to Malassezia was positive (≥0.35 kU/L) in 49.1% of patients. Men were significantly more often sensitized to Malassezia antigen (58% of men vs 42% of women; P value, 0.04). Concurrently, 58% of patients with HNAD versus 42% non-HNAD patients had higher levels of specific IgE to Malassezia, this difference being nearly significant (P value, 0.06). Patients with atopy were also more frequently sensitized to Malassezia. No significant relationship between EASI and the level of total IgE or specific IgE to Malassezia was observed.
CONCLUSIONS: In our population, IgE-mediated sensitization was found in up to 49% of all patients with AD, most common in men and in head and neck type.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24819285     DOI: 10.1097/DER.0000000000000040

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  8 in total

1.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  Precision Medicine and the Practice of Trichiatry: Adapting the Concept.

Authors:  Ralph M Trüeb; Vicky M L Jolliffe; Antonia Fellas Régnier; Hudson Dutra Rezende; Sergio Vañó-Galván; Daisy Kopera; Demetrios Ioannides; Maria Fernanda Reis Gavazzoni Dias; Melanie Macpherson; Aida Gadzhigoroeva; Julya Ovcharenko; Won-Soo Lee; Sundaram Murugusundram; Sotaro Kurata; Mimi Chang; Chuchai Tanglertsampan
Journal:  Skin Appendage Disord       Date:  2019-08-20

Review 3.  Cutaneous Malassezia: Commensal, Pathogen, or Protector?

Authors:  Shree Harsha Vijaya Chandra; Ramasamy Srinivas; Thomas L Dawson; John E Common
Journal:  Front Cell Infect Microbiol       Date:  2021-01-26       Impact factor: 5.293

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 5.  The Role of Malassezia spp. in Atopic Dermatitis.

Authors:  Martin Glatz; Philipp P Bosshard; Wolfram Hoetzenecker; Peter Schmid-Grendelmeier
Journal:  J Clin Med       Date:  2015-05-29       Impact factor: 4.241

Review 6.  Environment and Host-Genetic Determinants in Early Development of Allergic Asthma: Contribution of Fungi.

Authors:  Sabelo Hadebe; Frank Brombacher
Journal:  Front Immunol       Date:  2019-11-20       Impact factor: 7.561

Review 7.  Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment.

Authors:  Ditte M L Saunte; George Gaitanis; Roderick James Hay
Journal:  Front Cell Infect Microbiol       Date:  2020-03-20       Impact factor: 5.293

8.  Atopic Dermatitis and Sensitisation to Molecular Components of Alternaria, Cladosporium, Penicillium, Aspergillus, and Malassezia-Results of Allergy Explorer ALEX 2.

Authors:  Jarmila Celakovska; Radka Vankova; Josef Bukac; Eva Cermakova; Ctirad Andrys; Jan Krejsek
Journal:  J Fungi (Basel)       Date:  2021-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.